🔗 Share this article

The top legal official in Texas Ken Paxton is suing the manufacturers of Tylenol, asserting the companies hid alleged dangers that the pain reliever presented to children's cognitive development.

The lawsuit arrives thirty days after Former President Trump advocated an unverified association between using acetaminophen - referred to as paracetamol - while pregnant and autism spectrum disorder in children.

The attorney general is taking legal action against Johnson & Johnson, which previously sold the drug, the sole analgesic suggested for pregnant women, and Kenvue, which currently produces it.

In a statement, he claimed they "deceived the public by gaining financially from discomfort and marketing drugs regardless of the potential hazards."

The manufacturer says there is no credible evidence tying Tylenol to autism spectrum disorder.

"These companies lied for decades, intentionally threatening numerous people to line their pockets," the attorney general, from the Republican party, said.

The manufacturer commented that it was "very worried by the dissemination of inaccurate information on the reliability of acetaminophen and the likely effects that could have on the well-being of US mothers and children."

On its official site, the company also said it had "regularly reviewed the relevant science and there is no credible data that shows a established connection between using acetaminophen and autism."

Groups representing medical professionals and health professionals agree.

The leading OB-GYN organization has declared acetaminophen - the key substance in acetaminophen - is a restricted selection for expectant mothers to treat discomfort and elevated temperature, which can pose major wellness concerns if left untreated.

"In more than two decades of studies on the use of acetaminophen in pregnancy, zero credible investigations has conclusively proven that the use of acetaminophen in any stage of gestation causes neurodevelopmental disorders in children," the organization said.

The lawsuit references recent announcements from the previous government in arguing the medication is potentially dangerous.

In recent weeks, Trump caused concern from public health officials when he advised women during pregnancy to "resist strongly" not to take acetaminophen when unwell.

The FDA then published an announcement that medical professionals should think about restricting the usage of acetaminophen, while also mentioning that "a causal relationship" between the drug and autism spectrum disorder in young ones has not been proven.

The Health Department head RFK Jr, who oversees the Food and Drug Administration, had vowed in spring to undertake "extensive scientific investigation" that would determine the source of autism spectrum disorder in a limited time.

But authorities warned that discovering a single cause of autism - thought by researchers to be the result of a complex mix of inherited and external influences - would not be simple.

Autism spectrum disorder is a type of enduring cognitive variation and disability that influences how persons encounter and engage with the surroundings, and is diagnosed using doctors' observations.

In his lawsuit, Paxton - a Trump ally who is campaigning for federal office - claims Kenvue and Johnson & Johnson "deliberately disregarded and sought to suppress the evidence" around paracetamol and autism.

This legal action attempts to require the firms "remove any marketing or advertising" that states acetaminophen is secure for expectant mothers.

This legal action echoes the complaints of a collection of mothers and fathers of children with autism and attention deficit hyperactivity disorder who sued the makers of acetaminophen in 2022.

A federal judge threw out the case, stating investigations from the plaintiffs' authorities was lacking definitive proof.